Scientific evidence changes prescribing practice - A comparison of the management of the climacteric and use of hormone replacement therapy among Swedish gynaecologists in 1996 and 2003

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 113, Issue 1, 2006, Pages 15-20

  Thunell, Louise ^a,b   Milsom, Ian ^a   Schmidt, Johanna ^a   Mattsson, Lars Åke ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

BREAST CANCER; CANCER RISK; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG USE; EVIDENCE BASED MEDICINE; FEMALE; GYNECOLOGY; HEALTH SURVEY; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; KNOWLEDGE; LIFESTYLE; MALE; MENOPAUSAL SYNDROME; MENOPAUSE; NORMAL HUMAN; OSTEOPOROSIS; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SWEDEN; ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CLIMACTERIUM; CLINICAL PRACTICE; HEALTH PERSONNEL ATTITUDE; MIDDLE AGED;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; CLIMACTERIC; FEMALE; GYNECOLOGY; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; SWEDEN;

EID: 33644803430     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2005.00805.x     Document Type: Review

References (29)

1. Hammar M Berg G Fahraeus L Larsson-Cohn U Climacteric symptoms in an unselected sample of Swedish women Maturitas 1984 6 4 345 350
2. Stadberg E Mattsson LA Milsom I The prevalence and severity of climacteric symptoms and the use of different treatment regimens in a Swedish population Acta Obstet Gynecol Scand 1997 76 5 442 448
3. Li C Samsioe G Lidfelt J Nerbrand C Agardh CD Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study Menopause 2000 7 4 273 281
4. Falkeborn M Persson I Adami HO et al The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement Br J Obstet Gynaecol 1992 99 10 821 828
5. Grodstein F Stampfer MJ Manson JE et al Postmenopausal estrogen and progestin use and the risk of cardiovascular disease N Engl J Med 1996 335 7 453 461
6. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis Am J Med 1993 94 6 646 650
7. Rossouw JE Anderson GL Prentice RL et al Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 2002 288 3 321 333
8. Hulley S Grady D Bush T et al Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women JAMA 1998 280 7 605 613
9. Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer Lancet 1997 350 9084 1047 1059
10. Beral V Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 2003 362 9382 419 427
11. Castellsague J Perez Gutthann S Garcia Rodriguez LA Recent epidemiological studies of the association between hormone replacement therapy and venous thromboembolism. A review Drug Safety 1998 18 2 117 123
12. Estrogen use continues to decrease In Third Quarter Report on National Drug Use in Swedish The National Board of Health and Welfare Stockholm 2002 Available
13. Stadberg E Mattsson LA Milsom I Women's attitudes and knowledge about the climacteric period and its treatment. A Swedish population-based study Maturitas 1997 27 2 109 116
14. Sogaard AJ Tollan A Berntsen GK Fonnebo V Magnus JH Hormone replacement therapy: knowledge, attitudes, self-reported use-and sales figures in Nordic women Maturitas 2000 35 3 201 214
15. Andersson K Mattsson LA Milsom I Use of hormone replacement therapy Lancet 1996 348 9040 1521
16. Moen MH Fredriksen T Nilsen ST Iversen OE Use of hormone replacement therapy among female gynecologists and partners of male gynecologists in Norway Tidsskr Nor Laegeforen 1998 118 19 2944 2946
17. McNagny SE Wenger NK Frank E Personal use of postmenopausal hormone replacement therapy by women physicians in the United States Ann Intern Med 1997 127 12 1093 1096
18. Isaacs AJ Britton AR McPherson K Utilisation of hormone replacement therapy by women doctors BMJ 1995 311 7017 1399 1401
19. Andersson K Pedersen AT Mattsson LA Milsom I Swedish gynecologists' and general practitioners' views on the climacteric period: knowledge, attitudes and management strategies Acta Obstet Gynecol Scand 1998 77 9 909 916
20. Thunell L Stadberg E Milsom I Mattsson LA Changes in attitudes, knowledge and hormone replacement therapy use: a comparative study in two random samples with 6-year interval Acta Obstet Gynecol Scand 2005 84 4 395 401
21. Godsland IF Manassiev NA Felton CV et al Effects of low and high dose oestradiol and dydrogesterone therapy on insulin and lipoprotein metabolism in healthy postmenopausal women Clin Endocrinol (Oxf) 2004 60 5 541 549
22. Andersson B Mattsson LA Hahn L et al Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus J Clin Endocrinol Metab 1997 82 2 638 643
23. Manson JE Rimm EB Colditz GA et al A prospective study of postmenopausal estrogen therapy and subsequent incidence of noninsulin-dependent diabetes mellitus Ann Epidemiol 1992 2 5 665 673
24. Margolis KL Bonds DE Rodabough RJ et al Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative hormone trial Diabetologia 2004 47 7 1175 1187
25. EMEA Public statement on recent publications regarding hormone replacement therapy 2003 EMEA/33065/03
26. Holmberg L Anderson H HABITS (hormonal replacement therapy after breast cancer - is it safe?), a randomised comparison: trial stopped Lancet 2004 363 9407 453 455
27. von Schoultz E Rutqvist LE Menopausal hormone therapy after breast cancer: the Stockholm randomized trial J Natl Cancer Inst 2005 97 7 533 535
28. Moen MH Nilsen ST Iversen OE A significant change in Norwegian gynecologist's attitude to hormone therapy is observed after the results of the Women's Health Initiative Study Acta Obstet Gynecol Scand 2005 84 1 92 93
29. Grady D Herrington D Bittner V et al Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II) JAMA 2002 288 1 49 57